Orthomol Vitamin C Depo

Orthomol Vitamin C Depo is a specialized dietary supplement designed to support the immune system through a controlled-release (depot) formulation of vitamin C. The brand Orthomol pharmazeutische Vertriebs GmbH was founded in 1991 by Dr. Kristian Glagau and Hans Dietl in Langenfeld, Germany. It is known for its orthomolecular medicine approach, focusing on high-dosage nutrient combinations.

The product is manufactured in Germany, maintaining strict quality standards typical for pharmaceutical-grade supplements. In 2024, the German healthcare group STADA Arzneimittel AG announced its intention to acquire Orthomol, a deal that integrates the family-owned premium brand into one of Europe's leading consumer health portfolios. This acquisition ensures that while the brand's scientific roots remain in Germany, it benefits from the global distribution network of a major healthcare conglomerate.